Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

NCT00002330 ·Status: COMPLETED ·Phase: NA

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir

NCT00002301 ·Status: UNKNOWN ·Phase: NA

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

NCT00001061 ·Status: COMPLETED ·Phase: PHASE2

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

NCT06909110 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS

NCT00000693 ·Status: COMPLETED ·Phase: NA

A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

NCT00002384 ·Status: UNKNOWN ·Phase: NA

A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients

NCT01753167 ·Status: COMPLETED ·Phase: PHASE2

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

NCT00002432 ·Status: COMPLETED ·Phase: NA

A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)

NCT00439803 ·Status: COMPLETED ·Phase: PHASE1

A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis

NCT00002169 ·Status: COMPLETED ·Phase: PHASE2

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

NCT01646645 ·Status: COMPLETED ·Phase: PHASE2

Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient

NCT00002025 ·Status: COMPLETED ·Phase: NA

A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease

NCT00000881 ·Status: WITHDRAWN ·Phase: PHASE1

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

NCT06494033 ·Status: RECRUITING

Viral Specific T-Lymphocytes to Treat Adenovirus or CMV

NCT04364178 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

NCT00947141 ·Status: COMPLETED ·Phase: PHASE4

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

NCT03266640 ·Status: RECRUITING ·Phase: PHASE2

A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

NCT05575492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants

NCT00722839 ·Status: COMPLETED ·Phase: PHASE1

Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

NCT04232280 ·Status: COMPLETED ·Phase: PHASE2

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

NCT04225923 ·Status: COMPLETED ·Phase: PHASE2

Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients

NCT05238220 ·Status: COMPLETED

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

NCT01986010 ·Status: COMPLETED ·Phase: PHASE1

A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

NCT00001089 ·Status: COMPLETED

Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease

NCT00004642 ·Status: COMPLETED ·Phase: PHASE1/PHASE2